Royalty Pharma Past Performance

How has Royalty Pharma performed over the past 5 years?

[object Object] Score


Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: RPRX has high quality earnings.

Growing Profit Margin: RPRX's current net profit margins (22.6%) are lower than last year (34.2%).

Past Earnings Growth Analysis

Earnings Trend: RPRX's earnings have declined by 26.5% per year over the past 5 years.

Accelerating Growth: RPRX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: RPRX had negative earnings growth (-35.3%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (8.4%).

Return on Equity

High ROE: RPRX's Return on Equity (8.6%) is considered low.

Discover strong past performing companies